These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 18325670)

  • 1. Association between the brain-derived neurotrophic factor Val66Met polymorphism and brain morphology in a Japanese sample of schizophrenia and healthy comparisons.
    Takahashi T; Suzuki M; Tsunoda M; Kawamura Y; Takahashi N; Tsuneki H; Kawasaki Y; Zhou SY; Kobayashi S; Sasaoka T; Seto H; Kurachi M; Ozaki N
    Neurosci Lett; 2008 Apr; 435(1):34-9. PubMed ID: 18325670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of brain-derived neurotrophic factor Val66Met polymorphism on hippocampal volume change in schizophrenia.
    Koolschijn PC; van Haren NE; Bakker SC; Hoogendoorn ML; Hulshoff Pol HE; Kahn RS
    Hippocampus; 2010 Sep; 20(9):1010-7. PubMed ID: 19714565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The BDNF Val66Met polymorphism impacts parahippocampal and amygdala volume in healthy humans: incremental support for a genetic risk factor for depression.
    Montag C; Weber B; Fliessbach K; Elger C; Reuter M
    Psychol Med; 2009 Nov; 39(11):1831-9. PubMed ID: 19335934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association of genotypic combination of the DRD3 and BDNF polymorphisms on the adhesio interthalamica and medial temporal lobe structures.
    Takahashi T; Suzuki M; Tsunoda M; Kawamura Y; Takahashi N; Maeno N; Kawasaki Y; Zhou SY; Hagino H; Niu L; Tsuneki H; Kobayashi S; Sasaoka T; Seto H; Kurachi M; Ozaki N
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul; 32(5):1236-42. PubMed ID: 18472202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism in schizophrenia is associated with age at onset and symptoms.
    Numata S; Ueno S; Iga J; Yamauchi K; Hongwei S; Ohta K; Kinouchi S; Shibuya-Tayoshi S; Tayoshi S; Aono M; Kameoka N; Sumitani S; Tomotake M; Kaneda Y; Taniguchi T; Ishimoto Y; Ohmori T
    Neurosci Lett; 2006 Jun; 401(1-2):1-5. PubMed ID: 16533563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain-derived neurotrophic factor polymorphism Val66Met influences cognitive abilities in the elderly.
    Miyajima F; Ollier W; Mayes A; Jackson A; Thacker N; Rabbitt P; Pendleton N; Horan M; Payton A
    Genes Brain Behav; 2008 Jun; 7(4):411-7. PubMed ID: 17973920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of the brain-derived neurotrophic factor Val66Met polymorphism with reduced hippocampal volumes in major depression.
    Frodl T; Schüle C; Schmitt G; Born C; Baghai T; Zill P; Bottlender R; Rupprecht R; Bondy B; Reiser M; Möller HJ; Meisenzahl EM
    Arch Gen Psychiatry; 2007 Apr; 64(4):410-6. PubMed ID: 17404118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Disrupted-in-Schizophrenia-1 Ser704Cys polymorphism and brain morphology in schizophrenia.
    Takahashi T; Suzuki M; Tsunoda M; Maeno N; Kawasaki Y; Zhou SY; Hagino H; Niu L; Tsuneki H; Kobayashi S; Sasaoka T; Seto H; Kurachi M; Ozaki N
    Psychiatry Res; 2009 May; 172(2):128-35. PubMed ID: 19304459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuronal correlates of brain-derived neurotrophic factor Val66Met polymorphism and morphometric abnormalities in bipolar disorder.
    Matsuo K; Walss-Bass C; Nery FG; Nicoletti MA; Hatch JP; Frey BN; Monkul ES; Zunta-Soares GB; Bowden CL; Escamilla MA; Soares JC
    Neuropsychopharmacology; 2009 Jul; 34(8):1904-13. PubMed ID: 19295510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prefrontal cognition in schizophrenia and bipolar illness in relation to Val66Met polymorphism of the brain-derived neurotrophic factor gene.
    Rybakowski JK; Borkowska A; Skibinska M; Szczepankiewicz A; Kapelski P; Leszczynska-Rodziewicz A; Czerski PM; Hauser J
    Psychiatry Clin Neurosci; 2006 Feb; 60(1):70-6. PubMed ID: 16472361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain-derived neurotrophic factor val66met polymorphism and volume of the hippocampal formation.
    Szeszko PR; Lipsky R; Mentschel C; Robinson D; Gunduz-Bruce H; Sevy S; Ashtari M; Napolitano B; Bilder RM; Kane JM; Goldman D; Malhotra AK
    Mol Psychiatry; 2005 Jul; 10(7):631-6. PubMed ID: 15768049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential contributions of prefrontal and temporolimbic pathology to mechanisms of psychosis.
    Suzuki M; Zhou SY; Takahashi T; Hagino H; Kawasaki Y; Niu L; Matsui M; Seto H; Kurachi M
    Brain; 2005 Sep; 128(Pt 9):2109-22. PubMed ID: 15930048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers.
    Ho BC; Milev P; O'Leary DS; Librant A; Andreasen NC; Wassink TH
    Arch Gen Psychiatry; 2006 Jul; 63(7):731-40. PubMed ID: 16818862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain-derived neurotrophic factor gene polymorphism (Val66Met) and citalopram response in major depressive disorder.
    Choi MJ; Kang RH; Lim SW; Oh KS; Lee MS
    Brain Res; 2006 Nov; 1118(1):176-82. PubMed ID: 16979146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Val66Met polymorphism of the brain-derived neurotrophic factor gene affects age-related brain morphology.
    Nemoto K; Ohnishi T; Mori T; Moriguchi Y; Hashimoto R; Asada T; Kunugi H
    Neurosci Lett; 2006 Apr 10-17; 397(1-2):25-9. PubMed ID: 16388901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BDNF Val66Met allele is associated with reduced hippocampal volume in healthy subjects.
    Bueller JA; Aftab M; Sen S; Gomez-Hassan D; Burmeister M; Zubieta JK
    Biol Psychiatry; 2006 May; 59(9):812-5. PubMed ID: 16442082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of the Met allele of the brain-derived neurotrophic factor Val66Met polymorphism to memory after aneurysmal subarachnoid hemorrhage.
    Vilkki J; Lappalainen J; Juvela S; Kanarek K; Hernesniemi JA; Siironen J
    Neurosurgery; 2008 Aug; 63(2):198-203; discussion 203. PubMed ID: 18797348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain-derived neurotrophic factor polymorphisms and frontal cortex morphology in schizophrenia.
    Varnäs K; Lawyer G; Jönsson EG; Kulle B; Nesvåg R; Hall H; Terenius L; Agartz I
    Psychiatr Genet; 2008 Aug; 18(4):177-83. PubMed ID: 18628679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of catechol-O-methyltransferase Val158Met polymorphism on neuropsychological and functional outcomes of classical rehabilitation and cognitive remediation in schizophrenia.
    Bosia M; Bechi M; Marino E; Anselmetti S; Poletti S; Cocchi F; Smeraldi E; Cavallaro R
    Neurosci Lett; 2007 May; 417(3):271-4. PubMed ID: 17383818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Volume reduction of the left planum temporale gray matter associated with long duration of untreated psychosis in schizophrenia: a preliminary report.
    Takahashi T; Suzuki M; Tanino R; Zhou SY; Hagino H; Niu L; Kawasaki Y; Seto H; Kurachi M
    Psychiatry Res; 2007 Apr; 154(3):209-19. PubMed ID: 17321114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.